Privia Health Profit Margin 2020-2023 | PRVA
Current and historical gross margin, operating margin and net profit margin for Privia Health (PRVA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Privia Health net profit margin as of December 31, 2023 is 1.39%.
| Privia Health Annual Profit Margins |
|---|
| Privia Health Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.135B | $1.658B |
| Privia Health Group Inc. is a technology-driven, physician enablement company which collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health Group Inc. is based in Arlington, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.221B | 21.82 |
| Inspire Medical Systems (INSP) | United States | $6.999B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.463B | 0.00 |
| Axonics (AXNX) | United States | $3.394B | 0.00 |
| 10x Genomics (TXG) | United States | $3.206B | 0.00 |
| Enovis (ENOV) | United States | $3.022B | 22.96 |
| Azenta (AZTA) | United States | $2.872B | 234.09 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.869B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.629B | 0.00 |
| Schrodinger (SDGR) | United States | $1.688B | 0.00 |
| Omnicell (OMCL) | United States | $1.246B | 30.48 |
| Phreesia (PHR) | United States | $1.154B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.793B | 0.00 |
| Standard BioTools (LAB) | United States | $0.685B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
| Talkspace (TALK) | United States | $0.520B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.332B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.328B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.323B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| American Well (AMWL) | United States | $0.156B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.152B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.147B | 0.00 |
| Augmedix (AUGX) | United States | $0.136B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.131B | 0.00 |
| Outset Medical (OM) | United States | $0.123B | 0.00 |
| TruBridge (TBRG) | United States | $0.115B | 4.91 |
| 111 (YI) | China | $0.084B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.077B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.045B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |